Mithra Produces First Commercial Myring Batch For Europe

Mithra has produced its first commercial batch of Myring (ethinylestradiol/etonogestrel) for the European market at its CDMO facility in Belgium, soon after striking a 20-year license and supply agreement with ITROM Pharmaceutical Group to sell the combined hormonal contraceptive vaginal ring in the Middle East.